Purdue: Amplified Sciences Receives $108K Flywheel Fund Investment to Develop Pancreatic Cancer Diagnostics
March 02, 2024
March 02, 2024
WEST LAFAYETTE, Indiana, March 2 -- Purdue University issued the following news release:
Amplified Sciences, a clinical-stage life sciences diagnostic company that licenses Purdue University innovations, has received $108,000 in two investments from the Flywheel Fund to develop its tests for early, more accurate detection of challenging diseases, starting with pancreatic cancer.
Amplified Sciences' diagnostic tests are based on technology invented by V. Jo Davisson, pr . . .
Amplified Sciences, a clinical-stage life sciences diagnostic company that licenses Purdue University innovations, has received $108,000 in two investments from the Flywheel Fund to develop its tests for early, more accurate detection of challenging diseases, starting with pancreatic cancer.
Amplified Sciences' diagnostic tests are based on technology invented by V. Jo Davisson, pr . . .